| Turkey | Austria | Spain | |
| HLA-typing | from $200 | from $500 | from $200 |
No hidden fees – just official clinic prices. Pay at the clinic for HLA-typing upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in HLA-typing and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your HLA-typing journey.
Professor Zafer Gülbaş — hematologist-oncologist, founder and director of the Bone Marrow Transplant Center at Anadolu Medical Center, which is among the largest in Europe.
Why patients choose and trust Dr. Gülbaş:
Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.
Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.
Dr. Bülent Ünal is a general surgeon and surgical oncologist. He is Head of General Surgery and Surgical Oncology at Florence Nightingale Hospital. He graduated from Çukurova University in 1996. He completed his general surgery residency at Ankara Numune Training and Research Hospital in 2001. He finished a minor specialization in surgical oncology at İnönü University in 2012.
In 2008, he was an NCI Short-Term Scientist at the University of Pittsburgh Medical Center for 10 months. He trained in sentinel node techniques and ductoscopy. In 2010, he completed transplantation and oncology training at the University of Giessen and Marburg. He has many international publications and book chapters. His co-authored series include 128 living-donor liver recipients, 26 Fournier gangrene cases, and 18 diaphragmatic injuries.
He serves on the Board of the Surgical Oncology Association. He is also a member of several Turkish and international surgical societies.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.